⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Injection site urticaria

6,058 total reports0.8% serious outcomes

6,058

Total Reports

Deaths

Hospitalizations

0.8

Severity Rate

% serious outcomes

About Injection site urticaria Reports

Injection site urticaria has been reported 6,058 times in VAERS from 1990 to 2026.

Of these reports, 0 were associated with death (0.00%) and 48 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Injection site urticaria is 0.8%.

Understanding Injection site urticaria in VAERS

•Temporal association only: These reports show Injection site urticaria occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Injection site urticaria. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.